PSME4 Degrades Acetylated YAP1 in the Nucleus of Mesenchymal Stem Cells
Intensive research has focused on minimizing the infarct area and stimulating endogenous regeneration after myocardial infarction. Our group previously elucidated that apicidin, a histone deacetylase (HDAC) inhibitor, robustly accelerates the cardiac commitment of naïve mesenchymal stem cells (MSCs)...
Main Authors: | Yong Sook Kim, Mira Kim, Dong Im Cho, Soo Yeon Lim, Ju Hee Jun, Mi Ra Kim, Bo Gyeong Kang, Gwang Hyeon Eom, Gaeun Kang, Somy Yoon, Youngkeun Ahn |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-08-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/14/8/1659 |
Similar Items
-
The Proteasome Activator PA200/PSME4: An Emerging New Player in Health and Disease
by: Ayse Seda Yazgili, et al.
Published: (2022-08-01) -
Comprehensive analysis of PSME3: from pan-cancer analysis to experimental validation
by: Chengyuan Dong, et al.
Published: (2024-01-01) -
PSME2 identifies immune-hot tumors in breast cancer and associates with well therapeutic response to immunotherapy
by: Cen Wu, et al.
Published: (2022-12-01) -
PSME3 promotes glycolysis and migration of gastric cancer cells via regulating the EGFR/c-myc pathway
by: Liang Han, et al.
Published: (2024-02-01) -
The proteasome activator subunit PSME1 promotes HBV replication by inhibiting the degradation of HBV core protein
by: Yu Liu, et al.
Published: (2024-11-01)